References
- de Broe M E, Paulus G J, Verpooten G A, Rods F, Buyssens N, Wedeen R, Van Hoof F, Tulkens PM. Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kid Int 1984; 25: 643–652
- Schor N, Ichikawa I, Rennke H G, Troy J L, Brenner BN. Pathophysiology of altered glomerular function in aminoglycoside-treated rats. Kid Int 1981; 19: 288–296
- Bennett W M, Wood C A, Houghton D C, Gilbert DN. Modification of experimental aminoglycoside nephrotoxicity. Am J Kid Dis 1986; 8: 292–296
- Teixeira R B, Kelley J, Alpert H, Pardo V, Vaamonde CA. Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat. Kid Int 1982; 21: 600–612
- Purnell J, Houghton D C, Porter G A, Bennett WM. Effect of amiloride on experimental gentamicin nephrotoxicity. Nephron 1985; 40: 166–170
- Zager R A, Sharma HM. Gentamicin increases renal susceptibility to an acute ischemic insult. J Lab Clin Med 1983; 101: 670–678
- Whelton A, Stout R L, Franklin W, Delgado F, Solez K. Castration prevents gentamicin-induced acute renal failure and tubular necrosis in Fischer rats. Abstr 8th Int Congr Nephrol, Athens 1981; 200
- Smith C R, Moore R D, Lietman PS. Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kid Dis 1986; 8: 308–313
- Sawyers C L, Moore R D, Lerner S A, Smith CR. A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis 1986; 153: 1062–1068
- Richmond J M, Sibbald W H, Linton A M, Linton AL. Patterns of urinary protein excretion in patients with sepsis. Nephron 1982; 31: 219–223
- Moore R D, Smith C R, Lietman PS. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 1986; 80: 1093–1097